期刊
AIDS RESEARCH AND HUMAN RETROVIRUSES
卷 35, 期 1, 页码 25-32出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/aid.2018.0161
关键词
HIV-1 pathogenesis; type 1 interferon; immune activation; persistent latent reservoir
资金
- NIAID NIH HHS [P30 AI094189] Funding Source: Medline
- NIDA NIH HHS [R01 DA016078] Funding Source: Medline
HIV-1 remains a chronic viral infection of global health importance. Although HIV-1 replication can be controlled by antiretroviral therapy (ART), there is no cure due to persistence of a long-lived latent reservoir. In addition, people living with HIV-1 who are taking ART still bear signatures of persistent immune activation that include continued type 1 interferon (IFN) signaling. Paradoxically, type 1 IFN exerts a limited role on the control of chronic HIV-1. Indeed, recent reports from humanized mice suggest that type 1 IFN may partly maintain the latent reservoir. In this review, we discuss the molecular interactions between HIV-1 and the type 1 IFN signaling pathway, and examine the efficacy of type 1 IFNs in vivo. We also explore whether limited type 1 IFN manipulation may have a therapeutic role.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据